Company / PP&E per Share
Protalix BioTherapeutics, Inc. PP&E per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.06
FY2025
5-year range
$0.06 / $0.14
FY2021-FY2025
Trend
+2.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share returned to growth in FY2025 after 5 years of decline, reaching $0.06.
Based on SEC 10-K filings.
0.06 in FY2025 with a 10-year CAGR of -4.7%.
Declined from $0.09 to $0.06 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -13.7%
- 5-Year CAGR
- -27.7%
- 10-Year CAGR
- -4.7%
Key checks
Key Insights
- In FY2025, pp&e per share increased 2.2% year-over-year.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | +2.2% |
| FY2024 | $0.06 | -31.9% |
| FY2023 | $0.09 | -7.5% |
| FY2022 | $0.10 | -30.0% |
| FY2021 | $0.14 | -56.3% |
| FY2020 | $0.33 | -8.1% |
| FY2019 | $0.36 | +474.7% |
| FY2017 | $0.06 | -29.1% |
| FY2016 | $0.09 | -16.2% |
| FY2015 | $0.10 | -13.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026